Nufarm Limited

As of September 30, 2025, Nufarm Limited carries a market capitalization of 877.17M, placing it among publicly traded companies globally. Its enterprise value stands at 1.70B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Nufarm Limited's next confirmed earnings release is scheduled for November 19, 2026.

As of September 30, 2025, Nufarm Limited has 383.04M shares outstanding.

These figures are as of September 30, 2025. The price-to-sales ratio is 0.25, and the price-to-book ratio stands at 0.42.

These figures are as of September 30, 2025. The EV/Sales ratio of 0.49 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.70B versus a market cap of 877.17M, with the gap driven by net debt and cash on the balance sheet.

As of September 30, 2025, Nufarm Limited maintains a current ratio of 1.83, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 61.55, indicating elevated leverage, while an interest coverage ratio of -0.85 demonstrates limited ability to service its debt obligations.

Over the twelve months ended September 30, 2025, Nufarm Limited posted a negative return on equity (ROE) of -7.65, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.69, reflecting losses generated across the asset base. The company generates approximately 1.12M in revenue per employee across its workforce of 3,068.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.17 indicates how many times Nufarm Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended September 30, 2025, Nufarm Limited recorded an income tax benefit of -9.98M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -175.30M and -165.32M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Nufarm Limited's stock has gained approximately 40.65% over the past 52 weeks. The 50-day moving average sits at 3.14, while the 200-day moving average is 2.63.

Over the twelve months ended September 30, 2025, Nufarm Limited generated 3.44B in revenue and converted that into -165.32M in net income, yielding earnings per share of -0.43. EBITDA reached -78.06M, while operating income came in at -300.03M.

As of September 30, 2025, Nufarm Limited holds 474.72M in cash and equivalents against 1.30B in total debt, resulting in a net debt position of 672.07M. Total book value stands at 2.11B, with working capital of 1.04B providing operational flexibility.

These figures cover the twelve months ended September 30, 2025.

Over the twelve months ended September 30, 2025, Nufarm Limited posted a gross margin of 26.14, reflecting its pricing power and cost economics. The operating margin of -8.71 and net profit margin of -4.80 provide insight into operational efficiency.

Over the twelve months ended September 30, 2025, Nufarm Limited paid dividends of 0.06 per share. The dividend payout ratio of -13.10 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield is negative at -9.56, meaning Nufarm Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Nufarm Limited's most recent stock split took place on October 1, 2018 with a 284:289 split ratio.

As of September 30, 2025, Nufarm Limited has an Altman Z-Score of 1.25, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.